-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2023.
- Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$148K, a 188% decline year-over-year.
- Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$681K, a 62.1% increase year-over-year.
- Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.89M, a 36.9% decline from 2022.
- Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.38M, a 80.6% increase from 2021.
- Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$7.12M, a 22.9% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)